BERKELEY HEIGHTS, N.J., Feb. 1, 2011 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), (“Cyclacel” or the “Company”) today announced that the Company will present at the 13th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria Hotel in New York City. Spiro Rombotis, President and Chief Executive Officer, will provide an overview of the Company and its progress in key programs on Tuesday, February 15, 2011 at 9:00 a.m. Eastern in the Conrad Room. Cyclacel’s presentation will be webcast live and archived for 90 days on the Corporate Presentations page of the Cyclacel website at www.cyclacel.com.
